We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Combination Therapy Improves Survival Rates for Women With Aggressive Endometrial Cancer in Phase 2 Trial

News   Jun 30, 2020 | Original story from Yale School of Medicine

 
Combination Therapy Improves Survival Rates for Women With Aggressive Endometrial Cancer in Phase 2 Trial
 
 
Advertisement
 

RELATED ARTICLES

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

Artificial Pancreas Upgraded With AI Algorithm

News

Diabetes is a permanent condition that requires lifetime care, and the incidence is rising. To help manage it, an artificial pancreas system can be utilized which has been upgraded with an AI algorithm. The system automatically measures blood sugar levels to infuse the appropriate amount of insulin into the blood.

READ MORE

HER2 Breast Cancer Cells Adopt Strategy To Resist Immunotherapy

News

Findings from a study published in Nature Communications reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE